Abstract:Background: Coenzyme Q(10) (CoQ(10)) and its analogs are used therapeutically by virtue of their functions as electron carriers, antioxidant compounds, or both. However, published studies suggest that different ubiquinone analogs may produce divergent effects on oxidative phosphorylation and oxidative stress. Methodology/principal findings: To test these concepts, we have evaluated the effects of CoQ(10), coenzyme Q(2) (CoQ(2)), idebenone, and vitamin C on bioenergetics and oxidative stress in human skin fibroblasts with primary CoQ(10) deficiency. A final concentration of 5 microM of each compound was chosen to approximate the plasma concentration of CoQ(10) of patients treated with oral ubiquinone. CoQ(10) supplementation for one week but not for 24 hours doubled ATP levels and ATP/ADP ratio in CoQ(10) deficient fibroblasts therein normalizing the bioenergetics status of the cells. Other compounds did not affect cellular bioenergetics. In COQ2 mutant fibroblasts, increased superoxide anion production and oxidative stress-induced cell death were normalized by all supplements. Conclusions/significance: THESE RESULTS INDICATE THAT: 1) pharmacokinetics of CoQ(10) in reaching the mitochondrial respiratory chain is delayed; 2) short-tail ubiquinone analogs cannot replace CoQ(10) in the mitochondrial respiratory chain under conditions of CoQ(10) deficiency; and 3) oxidative stress and cell death can be counteracted by administration of lipophilic or hydrophilic antioxidants. The results of our in vitro experiments suggest that primary CoQ(10) deficiencies should be treated with CoQ(10) supplementation but not with short-tail ubiquinone analogs, such as idebenone or CoQ(2). Complementary administration of antioxidants with high bioavailability should be considered if oxidative stress is present.

Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics

Coenzyme Q10: Novel Formulations and Medical Trends

Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases

Coenzyme Q10 Supplementation in Aging and Disease

Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases

Coenzyme Q10 and Cardiovascular Diseases

Coenzyme Q10 supplementation – In ageing and disease

Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects

Primary Coenzyme Q10 Deficiency: An Update

Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges

The Use of Coenzyme Q10 in Cardiovascular Diseases

Metabolic Targets of Coenzyme Q10 in Mitochondria

Impact of Chemical Analogs of 4-Hydroxybenzoic Acid on Coenzyme Q Biosynthesis: From Inhibition to Bypass of Coenzyme Q Deficiency

Clinical aspects of coenzyme Q10: An update

Bioavailability enhancement of coenzyme Q10: An update of novel approaches

Coenzyme Q-10 in Human Health: Supporting Evidence?

Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications

CoQ10 a super-vitamin: review on application and biosynthesis

Coenzyme Q10: Clinical Applications in Cardiovascular Diseases

Coenzyme Q10: A Ubiquitous Supplemental Enzyme Contributing to the Health

The Emerging Role Of Coenzyme Q-10 In Aging, Neurodegeneration, Cardiovascular Disease, Cancer And Diabetes Mellitus